UnitedHealth Group Incorporated Q2 FY2026 income statement | sankey.it

UNHQ2 FY2026

UnitedHealth Group Incorporated

USD, quarter ended 2026-06-30

Operating Expenses: R&D 0% | SG&A 0% of revenue

Revenue

$112.0B+0.4%

Gross margin

32.7%+15 pts

Operating margin

7.1%+2.5 pts

Net margin

4.9%+1.8 pts

Open full screen

Revenue segments

No segment breakdown available for this filing - the flow shows revenue narrowing straight into cost and profit.

Period history

Revenue, by quarter

Income statement

Line	Q2 FY2026	YoY
Revenue	$112,032,000,000	+0.4%
Cost of revenue	$75,358,000,000	-18%
Gross profit	$36,674,000,000	+83%
Operating expenses	$28,683,000,000	+93%
Operating income	$7,991,000,000	+55%
Other income/expense, net	-$1,023,000,000	+4.2%
Income before tax

More in Healthcare

LLY+48%Q2 FY2026

Eli Lilly and Company

Fiscal period end: June 30, 2026
Source: Financial Modeling Prep, via the DATA project
Diagram generated: September 3, 2026